131 related articles for article (PubMed ID: 17187696)
1. Controversies in prostate cancer staging implementation at a tertiary cancer center.
Sexton T; Rodrigues G; Brecevic E; Boyce L; Parrack D; Lock M; D'Souza D
Can J Urol; 2006 Dec; 13(6):3327-34. PubMed ID: 17187696
[TBL] [Abstract][Full Text] [Related]
2. Capturing tumour stage in a cancer information database.
Evans WK; Crook J; Read D; Morriss J; Logan DM
Cancer Prev Control; 1998 Dec; 2(6):304-9. PubMed ID: 10470461
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer center.
Brierley JD; Catton PA; O'Sullivan B; Dancey JE; Dowling AJ; Irish JC; McGowan TS; Sturgeon JF; Swallow CJ; Rodrigues GB; Panzarella T
J Clin Oncol; 2002 Jan; 20(2):413-9. PubMed ID: 11786568
[TBL] [Abstract][Full Text] [Related]
4. Audit of prostate cancer: validity and feasibility of registry-based staging.
Silcocks P; Needham P; Hemsley F
Public Health; 1999 Jul; 113(4):157-60. PubMed ID: 10483075
[TBL] [Abstract][Full Text] [Related]
5. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
[TBL] [Abstract][Full Text] [Related]
6. Audit of prostate cancer: lessons learnt for current clinical practice, surrogates for quality of care and standardisation and quality assurance.
Silcocks P; Needham P; Hemsley F
Public Health; 1999 Jul; 113(4):161-4. PubMed ID: 10483076
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer.
Hong SK; Han BK; Chung JS; Park DS; Jeong SJ; Byun SS; Choe G; Lee SE
BJU Int; 2008 Nov; 102(9):1092-6. PubMed ID: 18671786
[TBL] [Abstract][Full Text] [Related]
8. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
[TBL] [Abstract][Full Text] [Related]
9. Variations in quality of care for men with early-stage prostate cancer.
Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the oncology patients information system in a regional cancer centre.
Yau JC; Chan A; Eapen T; Oirourke K; Eapen L
Oncol Rep; 2002; 9(1):167-9. PubMed ID: 11748476
[TBL] [Abstract][Full Text] [Related]
11. Pathology reporting of rectal cancer: a national audit.
Keating J; Lolohea S; Kenwright D
N Z Med J; 2003 Jul; 116(1178):U514. PubMed ID: 12897882
[TBL] [Abstract][Full Text] [Related]
12. Issues in the implementation of cancer staging in Canada.
Mackillop WJ; Catton P; Ashbury FD; McIntyre M
Cancer Prev Control; 1998 Dec; 2(6):299-303. PubMed ID: 10470460
[TBL] [Abstract][Full Text] [Related]
13. Comparison of New Zealand Cancer Registry data with an independent lung cancer audit.
Stevens W; Stevens G; Kolbe J; Cox B
N Z Med J; 2008 Jun; 121(1276):29-41. PubMed ID: 18574507
[TBL] [Abstract][Full Text] [Related]
14. Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer.
Park BK; Kim B; Kim CK; Lee HM; Kwon GY
J Comput Assist Tomogr; 2007; 31(4):534-8. PubMed ID: 17882027
[TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures.
Desch CE; McNiff KK; Schneider EC; Schrag D; McClure J; Lepisto E; Donaldson MS; Kahn KL; Weeks JC; Ko CY; Stewart AK; Edge SB
J Clin Oncol; 2008 Jul; 26(21):3631-7. PubMed ID: 18640941
[TBL] [Abstract][Full Text] [Related]
16. Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer.
Stalfors J; Lundberg C; Westin T
Acta Otolaryngol; 2007 Jan; 127(1):82-7. PubMed ID: 17364335
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA
BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
[TBL] [Abstract][Full Text] [Related]
18. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
[TBL] [Abstract][Full Text] [Related]
19. When is a pathology review indicated in endometrial cancer?
Kwon JS; Francis JA; Qiu F; Weir MM; Ettler HC
Obstet Gynecol; 2007 Dec; 110(6):1224-30. PubMed ID: 18055713
[TBL] [Abstract][Full Text] [Related]
20. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
Dahm P; Yeung LL; Chang SS; Cookson MS
J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
